◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Otsuka Holdings Co., Ltd. (4578) Financial History

Name: Otsuka Holdings Co., Ltd. (4578) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - General · DATA UPDATED 2026-08-11

Otsuka Holdings Co., Ltd. (4578) operates in the Drug Manufacturers - General industry and is headquartered in Chiyoda, Japan with about 37,758 employees. Its market capitalization is roughly JPY 6.60 trillion. In the fiscal year ended 2025-12-31, 4578 reported JPY 2.47T in revenue and JPY 363.1B in net income.

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Interactive charts & full statements →

4578 Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Total Revenue	JPY 2.47T	JPY 2.33T	JPY 2.02T	JPY 1.74T
Gross Profit	JPY 1.77T	JPY 1.67T	JPY 1.41T	JPY 1.17T
Operating Income (EBIT)	JPY 472.1B	JPY 416.0B	JPY 291.7B	JPY 186.1B
Net Income	JPY 363.1B	JPY 343.1B	JPY 121.6B	JPY 133.9B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4578 Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	(JPY 71.0B)	(JPY 66.8B)	(JPY 55.7B)	(JPY 55.6B)	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4578 Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Total Assets	JPY 4.20T	JPY 3.74T	JPY 3.36T	JPY 3.10T
Total Liabilities	JPY 1.10T	JPY 961.1B	JPY 924.9B	JPY 840.3B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4578 viewer.

4578 Metric Deep Dives

Other Companies in Drug Manufacturers - General

4519 · Chugai Pharmaceutical Co., Ltd. — $11.70 trillion
4568 · Daiichi Sankyo Company, Limited — $5.10 trillion
4503 · Astellas Pharma Inc. — $4.24 trillion
4528 · Ono Pharmaceutical Co., Ltd. — $1.14 trillion
4536 · Santen Pharmaceutical Co., Ltd. — $625 billion
NOVN · Novartis AG — $233 billion
1093 · CSPC Pharmaceutical Group Limited — $98 billion
GSK · GSK plc — $73 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← 4577 All “0-9” companies 4587 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.